IL33 and leukemia: Previously, we showed that IL1RL1, the receptor of IL-33, is highly expressed in leukemia cells expressing Cbfb-MYH11, and exogenous treatment with IL-33 promoted the survival of both primary mouse leukemia cells and human AML cell lines in vitro (16, 18).